Work

Clinical Outcomes for Patients with Myeloid Malignancies Harboring IDH1/2mutations after Intensive Chemotherapy

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-119306

Authors: Swapna Thota, Bhumika J. Patel, Hetty E. Carraway, Elizabeth A. Griffiths, Amanda Przespolewski, James E. Thompson, Teodora Kuzmanovic, Aziz Nazha, Shimoli Vipul Barot, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Sudipto Mukherjee, Meghan Scully, Aaron T. Gerds, Anjali S. Advani, Mikkael A. Sekeres, Manja Meggendorfer, Eunice S. Wang, Jaroslaw P. Maciejewski

Institutions: Roswell Park Comprehensive Cancer Center, Cleveland Clinic, Munich Leukemia Laboratory (Germany)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2908220784

Cites:

Cited by: 2

Related to: 10